Keith A. Delman
- Oncology top 1%
- Cutaneous Melanoma Detection and Management 59
- CAR-T cell therapy research 29
- Hepatology top 1%
- Epidemiology top 2%
- Nonmelanoma Skin Cancer Studies 25
- Herpesvirus Infections and Treatments 12
- Genetics top 2%
- Virus-based gene therapy research 23
- Immunology top 5%
- Immunotherapy and Immune Responses 18
-
- Melanoma and MAPK Pathways 17
-
- Innovations in Medical Education 14
- Co-authors
- Jonathan S. ZagerDavid A. KoobyViraj A. MasterYuman FongCharles A. StaleyDavid H. LawsonIwao IkaiYoshio Yamaoka
- Cited by
- OncologyHepatologyEpidemiology
- Journals
- Journal of Clinical Oncology (19 papers)SHILAP Revista de lepidopterología (1 paper)Hepatology (1 paper)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Keith A. Delman
146 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 124
- Oncology 2.4k
- Hepatology 675
- Epidemiology 1.3k
- Genetics 895
- Immunology 645
Countries citing papers authored by Keith A. Delman
This map shows the geographic impact of Keith A. Delman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith A. Delman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith A. Delman more than expected).
Fields of papers citing papers by Keith A. Delman
This network shows the impact of papers produced by Keith A. Delman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith A. Delman. The network helps show where Keith A. Delman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Keith A. Delman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2021 | 14 | |
| 3 | 2020 | 31 | |
| 4 | 2019 | 11 | |
| 5 | 2015 | 116 | |
| 6 | 2015 | 18 | |
| 7 | 2015 | 4 | |
| 8 | 2015 | 29 | |
| 9 | 2012 | 15 | |
| 10 | 2012 | 19 | |
| 11 | 2011 | 90 | |
| 12 | 2010 | 5 | |
| 13 | 2010 | 1 | |
| 14 | 2010 | 68 | |
| 15 | 2009 | 48 | |
| 16 | 2008 | 16 | |
| 17 | 2007 | 14 | |
| 18 | 2002 | 23 | |
| 19 | 2000 | 25 | |
| 20 | 2000 | 47 |
About Keith A. Delman
Keith A. Delman is a scholar working on Oncology, Dermatology and Epidemiology, having authored 150 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (59 papers), CAR-T cell therapy research (29 papers), Nonmelanoma Skin Cancer Studies (25 papers), Virus-based gene therapy research (23 papers), Immunotherapy and Immune Responses (18 papers), Melanoma and MAPK Pathways (17 papers), Innovations in Medical Education (14 papers) and Herpesvirus Infections and Treatments (12 papers). The work is most often cited by research in Oncology (2.4k citations), Hepatology (675 citations) and Epidemiology (1.3k citations). Keith A. Delman has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jonathan S. Zager, David A. Kooby, Viraj A. Master, Yuman Fong, Charles A. Staley, David H. Lawson, Iwao Ikai, Yoshio Yamaoka, Timothy M. Pawlik and Jean‐Nicolas Vauthey. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.